Target intelligence / Profile preview

Androctonus australis hector venom neurotoxins (Aah toxins)

Target
Aah toxins
Molecular classification
Scorpion toxin, Neurotoxin, Ion channel modulator, Peptide
01

Overview

Androctonus australis hector (Aah) venom neurotoxins are a group of highly potent peptides produced by the North African fat-tailed scorpion, which are responsible for severe and often fatal envenomation in humans (PubMed: 11518353). These toxins primarily target voltage-gated sodium (Nav) channels, with the most lethal component, Aah II, acting as an alpha-toxin that binds to receptor site 3 (UniProt: P01484). By binding to this site, the toxins inhibit the inactivation of the sodium channel, leading to prolonged action potentials and a massive release of neurotransmitters, which triggers a life-threatening autonomic storm (PubMed: 10657230). Clinical manifestations include hypertension, pulmonary edema, and cardiovascular collapse, making these toxins a major public health concern in endemic regions (PubMed: 15649515). While they are not therapeutic targets in the traditional sense, they are the primary focus for the development of antivenoms and serve as essential pharmacological tools for studying ion channel physiology (PubMed: 12126521).

Other names
AahIAahIIAahIIIAahIVAah ITAlpha-mammal toxins from Androctonus australisScorpion venom neurotoxins
02

Mechanism of action

The neurotoxins bind to specific sites on voltage-gated sodium channels; alpha-toxins bind to site 3 to inhibit inactivation, while beta-toxins bind to site 4 to shift the voltage-dependence of activation, both leading to prolonged depolarization and repetitive firing of neurons (PubMed: 10657230).

03

Biological functions

Sodium channel inactivation inhibitionNeurotransmitter release inductionMembrane depolarizationIon channel modulation
04

Disease associations

Scorpion envenomationAutonomic nervous system stormAcute pulmonary edemaNeurotoxicity
05

Safety considerations

Extreme lethality (low LD50)Rapid systemic distributionRisk of anaphylaxis or serum sickness from equine-derived antivenoms
06

Interacting drugs

Scorpion antivenom

3 more in the full profile.

07

Biomarkers

Serum venom antigensBlood glucose (hyperglycemia)Cardiac troponin ILeukocytosis

Beyond the preview

Go deeper on Androctonus australis hector venom neurotoxins (Aah toxins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Androctonus australis hector venom neurotoxins (Aah toxins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call